Skip to main content
. 2018 May 31;2018(5):CD003220. doi: 10.1002/14651858.CD003220.pub3

NCT01591278.

Trial name or title MTA and Biodentine in Pulpotomized Primary Molars
Methods Parallel RCT
Participants Age 4 to 9 years
Inclusion criteria
  • Molars showing:

    • symptomless exposure of vital pulp by caries

    • no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter‐radicular and/or furcal bone destruction)

    • the possibility of proper restoration of the teeth

    • no physiological resorption of more than one‐third of the root


Exclusion criteria
  • Presence of systemic pathology and any history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Interventions Biodentine and MTA
Outcomes Primary
  • Number of molars with clinical success (time frame 12 months)

  • Number of molars with radiographic success (time frame: 6 and 12 months)


Secondary
  • Number of molars with no evidence of radicular radiolucency

  • Number of molars with no evidence of internal resorption

  • Number of molars with no evidence of external resorption

  • Number of molars with no evidence of furcation radiolucency

  • Number of molars with no symptoms of pain

  • Number of molars without swelling

  • Number of molars without fistulation

  • Number of molars without pathological mobility


Time frame for all secondary outcomes: 6 and 12 months
Starting date March 2012
Contact information Cristina Cuadros, International University of Catalonia
Notes